Active metabolite: (prodrug
dephosphorilated by alkaline phosphatase to)phenytoin
U.S. Preparations:
Cerebyx® (Pfizer) FDA
approved:
1996 parenteral administration for control of generalized convulsive status
epilepticus and prevention and treatment of seizures occurring during
neurosurgery U.S. Prescribing information
